The effect of naringenin on TGF-β1/Smad pathway in HBE cells
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the effect of naringenin on TGF-β1/Smad pathway in human bronchial epithelial cells. Methods:HBE cells were divided into the control group,the TGF-β1 group and the naringenin group. The naringenin groups were incubated with different doses of naringenin (25,50 and 100 mol/L) for 2 h. Then the naringenin group and the TGF-β1 group were incubated with TGF-β1. After 2 h,we determined the PAI-1 mRNA level by real time-PCR. After incubated with TGF-β1 for 30 min,we detected Smad2 and Smad2 phosphorylation by Western. Smad2 nuclear translocation was analyzed by indirect immunofluorescent staining. Results:Compared with the control group,the expression of PAI-1 mRNA was significantly increasing in HBE cells stimulated with TGF-β1. Naringenin has inhibitory effects on the expression of PAI-1 mRNA. The totle of Smad2 was similar in different groups. Compared with the control group,phosphorylated-Smad2 was increasing in the TGF-β1 group. Naringenin could significantly inhibit the Smad2 phosphorylation. Immunofluorescent staining showed that the nuclear content of Smad2 in the TGF-β1 group was increased,and in the naringenin group(100 -滋mol/L) was decreased. Conclusion:Naringenin may inhibit TGF-β1/Smad through attenuated Smad2 phosphorylation and suppressed the nuclear content of Smad2 in human bronchial epithelial cells.

    Reference
    Related
    Cited by
Get Citation

Shi Ying, Gu Wei, Sun Lihua, Tan Yan. The effect of naringenin on TGF-β1/Smad pathway in HBE cells[J].,2013,(2):155-159.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 07,2012
  • Revised:
  • Adopted:
  • Online: March 05,2013
  • Published:
Article QR Code